Fellow of the European Confederation of Medical Mycology (ECMM)
Her primary areas of investigation include Microbiology, Aspergillus fumigatus, Aspergillosis, Aspergillus and Immunology. Intestinal mucosa, Micrococcus luteus, Propionibacterium freudenreichii and Bacteria is closely connected to Galactomannan in her research, which is encompassed under the umbrella topic of Microbiology. Her biological study spans a wide range of topics, including Paediatric department, Tumor necrosis factor alpha, Fungi imperfecti, Monocyte and Proinflammatory cytokine.
Her Aspergillosis research is multidisciplinary, incorporating perspectives in Voriconazole, Azole resistance, Micafungin, Antibiotic resistance and Mycosis. She works mostly in the field of Aspergillus, limiting it down to topics relating to Antifungal and, in certain cases, Aspergillus species and In vitro. Her research in the fields of Antibody, Hypogammaglobulinemia, Germinal center and Somatic hypermutation overlaps with other disciplines such as Nijmegen breakage syndrome.
Adilia Warris focuses on Immunology, Aspergillus fumigatus, Microbiology, Aspergillosis and Intensive care medicine. Her work carried out in the field of Immunology brings together such families of science as Peripheral blood mononuclear cell, Cystic fibrosis and Disease. Her study in Aspergillus fumigatus is interdisciplinary in nature, drawing from both Tumor necrosis factor alpha, Itraconazole, Genotype, Innate immune system and Drug resistance.
She studies Microbiology, namely Aspergillus. Her research in Aspergillosis intersects with topics in Voriconazole and Mycosis. Her studies examine the connections between Intensive care medicine and genetics, as well as such issues in Internal medicine, with regards to Fluconazole.
The scientist’s investigation covers issues in Intensive care medicine, Aspergillus fumigatus, Aspergillosis, Internal medicine and Clinical trial. Her Intensive care medicine research is multidisciplinary, incorporating perspectives in Epidemiology, Invasive candidiasis, Guideline, Antimicrobial stewardship and Voriconazole. Her Aspergillus fumigatus study is concerned with the field of Microbiology as a whole.
Her Aspergillosis study improves the overall literature in Immunology. Her Internal medicine study incorporates themes from Gastroenterology, Antibiotic sensitivity and Meropenem. Her work deals with themes such as Invasive fungal disease, Cancer and Disease management, which intersect with Clinical trial.
Her scientific interests lie mostly in Epidemiology, Intensive care medicine, Clinical trial, Aspergillosis and Guideline. The Epidemiology study combines topics in areas such as Odds ratio, Candida parapsilosis, Retrospective cohort study, Postmenstrual Age and Confidence interval. Her biological study spans a wide range of topics, including Invasive fungal disease and Dematiaceous.
Her studies deal with areas such as Cancer and Disease management, Disease as well as Clinical trial. In her research, Immunity and Aspergillus fumigatus is intimately related to Innate immune system, which falls under the overarching field of Aspergillosis. Her study on Evasion is often connected to Transcriptional response as part of broader study in Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)
Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation
Andreas H. Groll;Elio Castagnola;Simone Cesaro;Jean Hugues Dalle.
Lancet Oncology (2014)
Aspergillus fumigatus Evades Immune Recognition during Germination through Loss of Toll-Like Receptor-4-Mediated Signal Transduction
Mihai G. Netea;Adilia Warris;Jos W. M. Van der Meer;Matthew J. Fenton.
The Journal of Infectious Diseases (2003)
Invasive pulmonary aspergillosis associated with infliximab therapy.
A. Warris;A. Bjorneklett;P. Gaustad.
The New England Journal of Medicine (2001)
Involvement of CD14 and toll-like receptors in activation of human monocytes by Aspergillus fumigatus hyphae.
J. E. Wang;A. Warris;E. A. Ellingsen;P. F. Jørgensen.
Infection and Immunity (2001)
Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.
J W M van der Linden;M C Arendrup;A Warris;Katrien Lagrou.
Emerging Infectious Diseases (2015)
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.
Paul E. Verweij;Michelle Ananda-Rajah;David Andes;Maiken C. Arendrup.
Drug Resistance Updates (2015)
Infection with multiple viruses is not associated with increased disease severity in children with bronchiolitis
H. Kim Brand;Ronald de Groot;Joep M.D. Galama;Marianne L. Brouwer.
Pediatric Pulmonology (2012)
Aspergillus species intrinsically resistant to antifungal agents
Jan W. M. Van Der Linden;Adilia Warris;Paul E. Verweij.
Medical Mycology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: